Basis of antifibrinolytic therapy
Open Access
- 1 January 1980
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. s3-14 (1) , 35-40
- https://doi.org/10.1136/jcp.s3-14.1.35
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Tranexamic Acid in Control of Haemorrhage after Dental Extraction in Haemophilia and Christmas DiseaseBMJ, 1972
- Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled TrialBritish Journal of Haematology, 1971
- Plasminogen-activator-producing TumourBMJ, 1969
- COMPARATIVE ACTIVITIES OF AMINO ACID AND POLYPEPTIDE INHIBITORS ON NATURAL AND SYNTHETIC SUBSTRATESAnnals of the New York Academy of Sciences, 1968
- In vitro and In vivo Studies with Trasylol, an Anticoagulant and a Fibrinolytic InhibitorBritish Journal of Haematology, 1968
- Biochemistry and Toxicology of Amikapron ®; The Antifibrinolytically Active Isomer of AMCHA. (A Comparative Study with ε‐Aminocaproic Acid)Acta Pharmacologica et Toxicologica, 1965
- Clinical Trial of Epsilon-aminocaproic Acid in Severe HaemophiliaBMJ, 1965
- Amino Methyl Cyclohexane Carboxylic Acid (AMCHA), A New Synthetic Fibrinolytic InhibitorBritish Journal of Haematology, 1965
- SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACIDThe Lancet, 1964
- Clinical Experiences with ε‐Aminocaproic Acid (ε‐ACA) as an Antifibrinolytic AgentActa Medica Scandinavica, 1961